Skip to main content

Table 5 Mean and (SD) of the different indices of the PERSEPP HRQoL questionnaire for the non-respondent and respondent groups at Pre 1, Pre 2 and Post 1

From: Fampridine and quality of life in individuals with multiple sclerosis

PERSEPP (%) (items) Non-respondent Respondent
Pre 1 Pre 2 Post 1 Post 2 Pre 1 Pre 2 Post 1 Post 2
Overall (33) 63.1 (17.1) 62.5 (16.6) 66.3 (17.6) 68.2 (18.6)* 60.9 (15.1) 62.4 (18.2) 66.4 (18.3) 70.6 (18.5) +
Social support (5) 85.5 (15.3) 85.5 (12.7) 87.7 (12.4) 87.9 (12.9) 91.2 (10.7) 88.8 (23.3) 87.2 (24.6) 89.1 (24.6)
Relationship dif. (9) 54.8 (23.8) 55.5 (24.4) 62.1 (23.1) 60.9 (22.8) 46.4 (20) 53.1 (23.9) 51.9 (26.7) 64.1 (25)
Fatigue (4) 43 (30.6) 43.6 (28.7) 48.2 (32.4) 47.6 (34.1) 44.6 (32.7) 45 (31.7) 63.1 (32.7) 66.2 (34)
State of mind and sleep disor. (7) 64.9 (24.8) 64 (28.8) 65.5 (27.7) 67.8 (28.8) 59.2 (25) 65.1 (22.7) 72.3 (24) 73.5 (23.5)
Time perspective (8) 59.7 (21.7) 58.1 (21.6) 62 (25.3) 66.7 (24.6)* 58 (23.3) 56 (23.1) 63.5 (23.3) 66.4 (21.3)
Relapse (15) 50.9 (26.1) 53.5 (23.9) 56.5 (25.8) 56.9 (30.5) 42 (19.2) 42.1 (19.9) 45.3 (16.7) 52.7 (22.4)
Modules         
Coping (8) 59.1 (20.5) 58.8 (20.5) 59.7 (20.8) 59.2 (20.6) 57.8 (15.8) 56.7 (17.2) 59.4 (22.2) 60 (21.2)
Symptoms (20) 56.2 (19) 56.8 (18.9) 58.9 (19.3) ** 64.1 (19.2) ** 50.8 (14.9) 51 (17.8) 61 (14.1) 60.1 (18.2)
Treatment (5) 86.4 (15.5) 80.8 (21.3) 79.8 (18.9) 87.2 (14.7)*** 87 (17.6) 71.3 (36.4) 84 (16.5) 89.1 (11.9)
  1. The italic values correspond statistical significant differences
  2. p < 0.05 Pre 2 versus Post 2
  3. ** p < 0.01 Pre 1 and Pre 2 versus Pre 1 and Post 2
  4. *** p < 0.01 Post 1 versus Post 2
  5. + p 0.01 Pre 1 versus Post 2
  6.  p < 0.05 Pre 1 versus Post 2
  7.  p < 0.05 Pre 1 and Pre 2 versus Post 1 and Post 2